BIOMAT Database Logo BIOMAT Database Logo

Effect of IL-1 receptor antagonist and antiserum to TNF-alpha on LPS-induced plasma ACTH and corticosterone rise in rats. 1994

O Ebisui, and J Fukata, and N Murakami, and H Kobayashi, and H Segawa, and S Muro, and I Hanaoka, and Y Naito, and Y Masui, and Y Ohmoto
Department of Medicine, Kyoto University, Faculty of Medicine, Japan.

Using an antiserum against tumor necrosis factor (TNF)-alpha and an interleukin (IL-1) receptor antagonist, we studied putative roles of these cytokines in mediating the endotoxin-induced elevation of plasma adrenocorticotropic hormone (ACTH) and corticosterone levels in freely moving rats. Intravenous administration of Escherichia coli lipopolysaccharide (LPS) increased plasma ACTH and corticosterone levels in a dose-dependent manner. The plasma corticosterone reached to its highest level among a series of experiments after the administration of even the smallest dose (0.03 microgram/kg) tested. Plasma ACTH and corticosterone levels in these rats were completely inhibited by the intravenous administration of anti-murine TNF-alpha-rabbit antiserum (anti-TNFAS) after the administration of LPS but not by the intravenous administration of IL-1 receptor antagonist (IL-1RA). On the other hand, both recombinant human IL-1RA and anti-TNFAS significantly inhibited plasma ACTH increase stimulated with 10 micrograms/kg LPS. These findings indicate that 1) when the plasma corticosterone increase induced by intravenous LPS remains below its maximum, the effect is exclusively mediated by TNF-alpha, and 2) when a larger amount of LPS is administered, both IL-1 beta and TNF-alpha participate at least in part in the hypothalamic-pituitary-adrenal axis activation.

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008297 Male Males
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D003345 Corticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
D000324 Adrenocorticotropic Hormone An anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP). ACTH,Adrenocorticotropin,Corticotropin,1-39 ACTH,ACTH (1-39),Adrenocorticotrophic Hormone,Corticotrophin,Corticotrophin (1-39),Corticotropin (1-39),Hormone, Adrenocorticotrophic,Hormone, Adrenocorticotropic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

O Ebisui, and J Fukata, and N Murakami, and H Kobayashi, and H Segawa, and S Muro, and I Hanaoka, and Y Naito, and Y Masui, and Y Ohmoto
Involvement of TNF alpha, IL-1 beta and IL-1 receptor antagonist in LPS-induced rabbit uveitis.
May 1998, Experimental eye research,
O Ebisui, and J Fukata, and N Murakami, and H Kobayashi, and H Segawa, and S Muro, and I Hanaoka, and Y Naito, and Y Masui, and Y Ohmoto
Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
May 1997, Laboratory investigation; a journal of technical methods and pathology,
O Ebisui, and J Fukata, and N Murakami, and H Kobayashi, and H Segawa, and S Muro, and I Hanaoka, and Y Naito, and Y Masui, and Y Ohmoto
Effect of Bordetella pertussis vaccine on plasma corticosterone level and on ACTH-induced corticosterone secretion in rats.
May 1973, Experientia,
O Ebisui, and J Fukata, and N Murakami, and H Kobayashi, and H Segawa, and S Muro, and I Hanaoka, and Y Naito, and Y Masui, and Y Ohmoto
Interleukin-1 beta (IL-1 beta), IL-1 receptor antagonist, and TNF alpha production in whole blood.
December 1992, Journal of leukocyte biology,
O Ebisui, and J Fukata, and N Murakami, and H Kobayashi, and H Segawa, and S Muro, and I Hanaoka, and Y Naito, and Y Masui, and Y Ohmoto
Human IL-1 receptor antagonist partially suppresses LPS fever but not plasma levels of IL-6 in Fischer rats.
September 1992, The American journal of physiology,
O Ebisui, and J Fukata, and N Murakami, and H Kobayashi, and H Segawa, and S Muro, and I Hanaoka, and Y Naito, and Y Masui, and Y Ohmoto
Systemic injection of TNF-alpha attenuates fever due to IL-1 beta and LPS in rats.
November 1992, The American journal of physiology,
O Ebisui, and J Fukata, and N Murakami, and H Kobayashi, and H Segawa, and S Muro, and I Hanaoka, and Y Naito, and Y Masui, and Y Ohmoto
[The role of TNF alpha, IL-1 beta and MIP-1 alpha in LPS-induced organ injury].
April 1996, Zhonghua yi xue za zhi,
O Ebisui, and J Fukata, and N Murakami, and H Kobayashi, and H Segawa, and S Muro, and I Hanaoka, and Y Naito, and Y Masui, and Y Ohmoto
Differential gene expression for IL-1 receptor antagonist, IL-1, and TNF receptors and IL-1 and TNF synthesis may explain IL-1-induced resistance to infection.
December 1994, Journal of immunology (Baltimore, Md. : 1950),
O Ebisui, and J Fukata, and N Murakami, and H Kobayashi, and H Segawa, and S Muro, and I Hanaoka, and Y Naito, and Y Masui, and Y Ohmoto
Influence of amlodipine and atenolol on lipopolysaccharide (LPS)-induced serum concentrations of TNF-alpha, IL-1, IL-6 in spontaneously hypertensive rats (SHR).
January 2006, Pharmacological reports : PR,
O Ebisui, and J Fukata, and N Murakami, and H Kobayashi, and H Segawa, and S Muro, and I Hanaoka, and Y Naito, and Y Masui, and Y Ohmoto
[Effect of hypoxia and hypercapnia on plasma ACTH and corticosterone in rats].
January 1976, Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
Copied contents to your clipboard!